REVERSAL OF GLIOBLASTOMA REPLICATIVE IMMORTALITY IN A TERT PROMOTER MUTATION-DEPENDENT MANNER

被引：0
|
作者：
Mancini, Andrew [1 ]
Xavier-Magalhaes, Ana [2 ]
Woods, Wendy [3 ]
Nguyen, Kien-Thiet [1 ]
Amen, Alexandra [4 ]
McKinney, Andrew [1 ]
Hayes, Josie [1 ]
Song, Jun [3 ]
Costa, Bruno [2 ]
Perez-Pinera, Pablo [3 ]
Costello, Joseph [5 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[2] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal
[3] Univ Illinois, Dept Bioengn, Champaign, IL 61820 USA
[4] Univ Calif Berkeley, Berkeley, CA 94720 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CSIG-38
引用
收藏
页码：57 / 58
页数：2
相关论文
共 35 条
  • [31] Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy
    Nguyen, HuyTram N.
    Lie, Amy
    Li, Tie
    Chowdhury, Reshmi
    Liu, Fei
    Ozer, Byram
    Wei, Bowen
    Green, Richard M.
    Ellingson, Benjamin M.
    Wang, He-jing
    Elashoff, Robert
    Liau, Linda M.
    Yong, William H.
    Nghiemphu, Phioanh L.
    Cloughesy, Timothy
    Lai, Albert
    NEURO-ONCOLOGY, 2017, 19 (03) : 394 - 404
  • [32] Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link?
    Weller, M.
    Gramatzki, D.
    Felsberg, J.
    Hentschel, B.
    Wolter, M.
    Schackert, G.
    Westphal, M.
    Regli, L.
    Thon, N.
    Tatagiba, M.
    Wick, W.
    Schlegel, U.
    Krex, D.
    Roth, P.
    Rushing, E.
    Pietsch, T.
    von Deimling, A.
    Sabel, M.
    Loeffler, M.
    Reifenberger, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S396 - S396
  • [33] Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
    Damian Stichel
    Azadeh Ebrahimi
    David Reuss
    Daniel Schrimpf
    Takahiro Ono
    Mitsuaki Shirahata
    Guido Reifenberger
    Michael Weller
    Daniel Hänggi
    Wolfgang Wick
    Christel Herold-Mende
    Manfred Westphal
    Sebastian Brandner
    Stefan M. Pfister
    David Capper
    Felix Sahm
    Andreas von Deimling
    Acta Neuropathologica, 2018, 136 : 793 - 803
  • [34] Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
    Stichel, Damian
    Ebrahimi, Azadeh
    Reuss, David
    Schrimpf, Daniel
    Ono, Takahiro
    Shirahata, Mitsuaki
    Reifenberger, Guido
    Weller, Michael
    Haenggi, Daniel
    Wick, Wolfgang
    Herold-Mende, Christel
    Westphal, Manfred
    Brandner, Sebastian
    Pfister, Stefan M.
    Capper, David
    Sahm, Felix
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2018, 136 (05) : 793 - 803
  • [35] Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using TERT promoter mutation-specific droplet digital PCR assays.
    Cordova, Christine
    Syeda, Mahrukh M.
    Corless, Broderick
    Wiggins, Jennifer M.
    Patel, Amie
    Kurz, Sylvia Christine
    Delara, Malcolm
    Sawaged, Zacharia
    Utate, Minerva
    Placantonakis, Dimitris
    Golfinos, John
    Schafrick, Jessica
    Silverman, Joshua Seth
    Jain, Rajan
    Snuderl, Matija
    Zagzag, David
    Shao, Yongzhao
    Karlin-Neumann, George Alan
    Polsky, David
    Chi, Andrew S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
1234